Recently, the flu has been frequent, many children and adults have been recruited, so the recent rise in pharmaceutical-related concept stocks is good, in the pharmaceutical commercial stocks, in addition to our common Tongrentang, Fosun Pharmaceutical, Shanghai Pharmaceutical, and a listed company has also performed very well, that is, Yixintang, how is this **?Let's take a brief look.
01 Basic information
The full name of Yixintang is Yixintang Pharmaceutical Group Co., Ltd., which is the largest pharmaceutical retail enterprise with the largest sales volume and the most outlets in Yunnan Province.
It was listed in 2014 and has increased by 3 times. The controlling shareholder is Ruan Hongxian, with a shareholding ratio of 3058%。
02 Performance
In 2009, Yixintang's operating income was 145.6 billion yuan, which will increase to 174 by 2022300 million yuan, maintaining a high rate of positive growth for 13 consecutive years, and in the first three quarters of 2023, the operating income will be 128100 million yuan, a year-on-year increase of 648%。
Net profit over the same period increased from 08.5 billion yuan, an increase of 10100 million yuan. In the first three quarters of 2023, the net profit will be 68.6 billion yuan, a year-on-year increase of 125%。
Overall, Yixintang's performance is still good. However, the growth rate has been declining year by year.
03 Asset quality
As of the third quarter of 2023, Yixintang has total assets of 16.3 billion yuan, liabilities of 8.3 billion yuan, net assets of 8 billion yuan, monetary cash of 3.3 billion, asset-liability ratio of 51%, and return on net assets of 9%.
Overall, asset quality is high.
04 SalesHairInterest rates
From 2012 to 2022, Yixintang's gross profit margin fluctuated between 30% and 40% overall, and in the third quarter of 2023, it was 33%.
05 Dividend valuation
Yixintang's current market capitalization is 13.3 billion yuan, with a dynamic P/E ratio of 15 times, a static P/E ratio of 13 times, and a P/B ratio of 17 times. Valuations are at a low level.
It has been paid out for 9 consecutive years, with a cumulative dividend of 1.5 billion yuan and a current dividend yield of 176%。
06 Summary
Overall, Yixintang performed better.